Krakchemia (WAR:KCH) Total Operating Expense: zł9.41 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:KCH Krakchemia SA WAR:KCH
35 GF Score
Price zł0.57
GF Value zł0.31
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Krakchemia Total Operating Expense?

Krakchemia WAR:KCH +25.44% 35 Total Operating Expense is zł9.41 Mil as of Mar. 2026. GuruFocus rates WAR:KCH with a GF Score™ of 35/100 and a GF Value™ of zł0.31 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Krakchemia's Total Operating Expense for the three months ended in Mar. 2026 was zł1.42 Mil. Krakchemia's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł9.41 Mil.

Krakchemia Total Operating Expense Related Terms

Krakchemia Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Krakchemia's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krakchemia Total Operating Expense Chart

Krakchemia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.90 13.17 53.77 11.78 9.82

Krakchemia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 2.34 2.25 3.41 1.42
WAR:KCH
35GF Score
Krakchemia SA WAR:KCH
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krakchemia Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł9.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of zł9.41 Mil mean?
Krakchemia (WAR:KCH) has a Total Operating Expense of zł9.41 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Krakchemia and its competitors.
Is Krakchemia's Total Operating Expense too high?
Krakchemia's current Total Operating Expense is zł9.41 Mil. Overall, Krakchemia has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krakchemia's Total Operating Expense compare to LIN and SHW?
Krakchemia's Total Operating Expense of zł9.41 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Chemicals company?
A good Total Operating Expense depends on the Chemicals industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Krakchemia and its competitors. Krakchemia's current Total Operating Expense is zł9.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krakchemia stock overvalued right now?
Based on GuruFocus' analysis, Krakchemia (WAR:KCH) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.31, compared to a current price of zł0.57 — trading 84.5% above its estimated fair value. The current Total Operating Expense is zł9.41 Mil. Krakchemia's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Krakchemia (WAR:KCH), the current Total Operating Expense is zł9.41 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krakchemia (WAR:KCH) Overvalued in 2026?

Based on GuruFocus' analysis, Krakchemia stock appears to be overvalued. The current stock price of zł0.57 is trading 84.5% above its estimated GF Value™ of zł0.31. GuruFocus considers Krakchemia to be Significantly Overvalued.

Key valuation signals for WAR:KCH:

  • Total Operating Expense: zł9.41 Mil
  • GF Value™: zł0.31 vs. price of zł0.57 (84.5% above fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the WAR:KCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krakchemia Business Description

Address 14 Listopadowego Uprising Street, Krakow, POL, 30-298
Krakchemia SA specializes in the wholesale of plastic granulates, laboratory chemicals, and chemical raw materials. The company's main activity is wholesale trade in chemical products, mainly plastic granulates, packaging foils, plastics, reagents, and chemical raw materials. It sells commercial goods on the domestic market and in small quantities abroad, with operations covering Poland, Slovakia, the Czech Republic, Germany, and other foreign markets.
35GF Score

Get the complete analysis for WAR:KCH

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.57
Price
zł0.31
GF Value